 MALVERN, Pa., April 01, 2021 GLOBE NEWSWIRE -- Baudax Bio, Inc. Nasdaq: BXRX, a pharmaceutical company focused on therapeutics for acute care settings, today announced that the Compensation Committee of Baudax Bios Board of Directors approved an inducement grant of stock options to purchase an aggregate of 7,500 shares of Baudax Bios common stock and restricted stock units covering 2,000 shares of Baudax Bios common stock in connection with one newly-hired employee with a grant date of March 31, 2021. The equity award was granted pursuant to the Nasdaq Rule 5635c4 inducement grant exception as a component of the individuals employment compensation and was granted as an inducement material to his acceptance of employment with Baudax Bio. 